Sunday, June 24, 2018

Indian drug firm challenges GSK, Pfizer in race for multi-billion-dollar aid-financed vaccine market

The Indian pharmaceutical company Serum Institute says its pneumonia vaccine will be ready for sale in developing countries by 2020 at a fraction of the going price. This places Serum in direct competition with two Western drug manufacturers, GSK and Pfizer, which have dominated the aid- financed pneumonia vaccine market for the last decade.

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.